During the past decade, South West Healthcare conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South West Healthcare" #1 sponsor was "Barwon Health" with 2 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Ipsen" with 1 trials sponsored, "Neuroscience Trials Australia" with 1 trials sponsored and "Olivia Newton-John Cancer Research Institute" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South West Healthcare" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "The Florey Institute of Neuroscience and Mental Health" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "South West Healthcare" are "Breast Cancer" (2 trials), "Advanced Biliary Tract Cancer" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Female Reproductive System Neoplasm" (1 trials) and "First Line Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "South West Healthcare" in a lesser frequency.

Most popular intervention types in "South West Healthcare" are "Drug" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "68Ga-FAPi-46" (1 trials), "Alendronate sodium" (1 trials), "Avelumab" (1 trials), "Avelumab Weekly" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "South West Healthcare" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "South West Healthcare". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in South West Healthcare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in South West Healthcare, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".